Results 211 to 220 of about 64,766 (258)
Some of the next articles are maybe not open access.

Malignant Hyperthermia

Southern Medical Journal, 1983
Malignant hyperthermia, a rapidly progressive, frequently lethal syndrome was not described until quite recently. Although treatment with the drug dantrolene has changed its face, a clear understanding and deep respect for the syndrome are necessary to keep fatalities and tragic sequelae to a minimum.
openaire   +4 more sources

Hyperthermia and thermochemotherapy

1993
The combination of anticancer drugs with hyperthermia was only recently introduced as an experimental clinical strategy. This approach within the field of medical oncology is based on the convincing evidence that hyperthermia enhances the therapeutic effect of several chemotherapeutic agents, even in drug-resistant cells. Such a combined modality is of
openaire   +2 more sources

HYPERTHERMIA AND CANCER

Australian and New Zealand Journal of Surgery, 1977
The effects of heat and its possible significance in cancer therapy have been documented for more than a century. Hyperthermia has been widely investigated as an alternative or adjuvant to conventional therapies such as surgery, radiation, and chemotherapy.
D, Burkhardt, P, Ghosh
openaire   +2 more sources

MALIGNANT HYPERTHERMIA

Acta Pathologica Japonica, 1982
A report is made of a 65‐year‐old male who died of a malignant hyperthermia of 42°C. Symptoms included muscle rigidity at the termination of operation for neck‐clipping of an aneurysm of the anterior communicating artery. Latent myopathy was observed in skeletal muscle, and a bleeding focus was present in the left anterior region of the hypothalamus ...
M, Ohmori   +3 more
openaire   +2 more sources

Malignant Hyperthermia

Pediatric Clinics of North America, 1994
Major advances have occurred in the management of MH since this disorder was first described. Despite the initially high mortality, deaths secondary to MH have dramatically decreased over the past 15 years, which is due in large part to the discovery of efficacious therapy.
S J, Kaus, M A, Rockoff
openaire   +2 more sources

Therapeutic hyperthermia

2018
The term hyperthermia broadly refers to either an abnormally high fever or the treatment of a disease by the induction of fever. Its effect depends on the temperature and exposure time. The increasing number of applications and clinical trials at universities, clinics, and hospitals prove the feasibility and applicability of clinical therapeutic ...
openaire   +2 more sources

Malignant hyperthermia

Best Practice & Research Clinical Anaesthesiology, 2003
Malignant hyperthermia (MH) is an uncommon, life-threatening, acute pharmacogenetic disorder of the skeletal muscle cell. It manifests in susceptible individuals as a hypermetabolic response on exposure to halogenated volatile anaesthetics and depolarizing muscle relaxants.
Ali SZ, Taguchi A, Rosenberg H
openaire   +3 more sources

Malignant hyperthermia

The American Journal of Surgery, 1977
Malignant hyperthermia of anesthesia is a severe complication and must be treated vigorously. The anesthetic should be stopped and the core body temperature reduced. Systemic complications must be anticipated, hopefully prevented, and appropriately treated. Appropriate laboratory studies must be obtained.
openaire   +2 more sources

Hyperthermia and fatigue

Journal of Applied Physiology, 2008
The present review addresses mechanisms of importance for hyperthermia-induced fatigue during short intense activities and prolonged exercise in the heat. Inferior performance during physical activities with intensities that elicit maximal oxygen uptake is to a large extent related to perturbation of the cardiovascular function, which eventually ...
openaire   +3 more sources

Malignant Hyperthermia or Not Malignant Hyperthermia

ICU Director, 2013
In an acute event, the diagnosis of malignant hyperthermia (MH) in patients in the ICU can be challenging. Initial presentation may be attributed to a gamut of causes, making the diagnosis complicated. This example is the case of a 46-year-old African American man who was admitted to the Stroke Service and intubated for respiratory distress.
Alexander F. Bautista   +1 more
openaire   +1 more source

Home - About - Disclaimer - Privacy